FDA Investigator: Seneca D. Toms

- Seneca D. Toms first started conducting FDA inspections in 2011, with the last inspection in 2023. Over that time, Seneca D. Toms has conducted 155 inspections at 135 companies across 133 sites.

Documents

FDA 483 Daizo Corporation, Kyoto | 2023

Out-of-stock
Seneca D. Toms
Human Drugs Form 483

FDA 483 New Vision Pharmaceuticals LLC, Tamarac | 2023

Out-of-stock
Seneca D. Toms
Human Drugs Form 483

FDA 483 Partner Therapeutics Inc, Lynnwood | 2022

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 FujiFilm Diosynth Biotechnologies U.S.A., Inc., Research Triangle Park | 2021

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 Catalent Pharma Solutions LLC, Morrisville | 2020

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 Glenmark Pharmaceuticals Inc USA, Monroe | 2019

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 Triangle Compounding Pharmacy Inc, Cary | 2019

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 KM PHARMACEUTICAL CO., LTD., Pyeongtaek | 2019

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, West Columbia | 2018

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 Canadian Custom Packaging Co., North York | 2018

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 Civentichem, LLC., Cary | 2018

Out-of-stock
Seneca D. Toms
Human Drug Form 483

FDA 483 BOV Solutions, Statesville | 2018

Out-of-stock
Seneca D. Toms
Human Drug Form 483

Co-Investigators (81)